Who Should I Start? Kendrick Bourne or Marquez Valdes-Scantling

Sunday, March 10, 9:22 PM

Wide receiver Kendrick Bourne agreed to a new deal to remain in New England. The contract is for three years, and he'll be eligible to earn up to $33 million. The 28-year-old amassed 406 yards and four touchdowns off 37 catches last season. However, despite appearing on track for a career year, Bourne suffered a torn ACL during the AFC East battle with the Miami Dolphins in Week 8. Fortunately, he should be ready to go for the 2024-25 campaign. But with a new head coach in the equation and Mac Jones out of the picture, Bourne could have a tough time finding his rhythm. His knee injury is also something fantasy managers should keep in the back of their heads. Yet, while reaching for him during fantasy drafts heading into the new season isn't recommended, he's worth grabbing if he's available later than expected.

Tuesday, May 14, 10:11 AM

The Buffalo Bills signed veteran wide receiver Marquez Valdes-Scantling to a one-year deal worth up to $4.5 million on Tuesday, according to ESPN's Adam Schefter. MVS is no stranger to playing with elite quarterbacks between his time with Aaron Rodgers in Green Bay and Patrick Mahomes in Kansas City, and he'll now be in line to catch passes from Josh Allen in Buffalo. The 2018 fifth-round pick out of South Florida has not posted monster fantasy football numbers, but he has spike-week upside thanks to his field-stretching speed. That said, he's likely going to be more useful in "real life" compared to fantasy football based on his production profile thus far. In six NFL seasons, the 29-year-old has not eclipsed 690 yards or six touchdowns in a single season. Last year, he caught just 21 passes for 315 yards and one touchdown in 16 games. He's an interesting late-round flyer in best ball formats, but he might be a wasted roster spot in traditional leagues. MVS will compete with Khalil Shakir and Curtis Samuel for snaps in 2024, as second-round rookie Keon Coleman should be a locked-in starter.